J. Stern & Co’s Eli Lilly LLY Stock Holding History

J. Stern & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.16M	Sell	4,519 -4,042,726	-100%	-$4.1B	0.4%	22
2025 Q4	$4.05B	Buy	4,047,245 +4,038,502	+46,191%	+$3.86B	0.34%	22
2025 Q3	$6.67M	Buy	8,743 +4,542	+108%	+$3.38M	0.5%	29
2025 Q2	$3M	Buy	4,201 +152	+4%	+$118K	0.26%	27
2025 Q1	$3.34M	Buy	4,049 +564	+16%	+$469K	0.32%	25
2024 Q4	$2.69M	Buy	3,485 +673	+24%	+$557K	0.25%	25
2024 Q3	$2.49M	Buy	2,812 +902	+47%	+$811K	0.27%	22
2024 Q2	$1.73M	Buy	+1,910	New	+$1.53M	0.21%	24
2024 Q1	–	Sell	-554	Closed	-$358K	–	42
2023 Q4	$358K	Buy	+554	New	+$323K	0.07%	26

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

J. Stern & Co's LLY Position: Q1 2026 in Review

J. Stern & Co reduced its Eli Lilly (LLY) stake by 100% in Q1 2026, selling an estimated $4.1B and leaving 4,519 shares worth $4.16M. The position accounts for 0.4% of the portfolio, ranked #22.

J. Stern & Co first reported a position in LLY in Q4 2023 and has held it in 9 quarters since. The position peaked at $4.05B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

J. Stern & Co held 4,519 shares of Eli Lilly worth $4.16M as of Q1 2026.
J. Stern & Co sold 4,042,726 Eli Lilly shares in Q1 2026, an estimated $4.1B.
Eli Lilly made up 0.4% of J. Stern & Co's portfolio in Q1 2026, its #22 holding.
J. Stern & Co first reported a position in Eli Lilly in Q4 2023 and has held it in 9 quarters since.
J. Stern & Co's Eli Lilly position peaked at $4.05B in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on J. Stern & Co's 13F filing for Q1 2026, filed 15 May 2026.